ArticleRespirology case reports2024
Exceptional long term response to crizotinib in ROS 1-postive advanced non small cell lung cancer.
Anjali Murali et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
1 paper cites it
this papercites it